Supply Chain Intelligence

Xilio Therapeutics, Inc. Supply Chain

XLO supply chain intelligence for Xilio Therapeutics, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

XLO ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

2Suppliers
6Customers
3Debt Items
20Related Chains

Xilio Therapeutics, Inc. Suppliers

TickerNameConfidenceEvidence
CELG-RI CELG-RI 72% voluntary cooperation in other areas. Individual EU member states will continue to be responsible for assessing non-clinical (e.g., economic, social, ethical) aspects of health technology, and making…
CELG-RI CELG-RI 72% Reciprocal relationship from CELG-RI graph: Reciprocal relationship from XLO graph: Reciprocal relationship from CELG-RI graph: Reciprocal relationship from XLO graph: voluntary cooperation in other …

Xilio Therapeutics, Inc. Customers

TickerNameConfidenceEvidence
ABBV AbbVie Inc. 92% upfront and milestone payments under our collaboration and license agreements with AbbVie
ABBV AbbVie Inc. 92% Reciprocal relationship from ABBV graph: Reciprocal relationship from XLO graph: Reciprocal relationship from ABBV graph: Reciprocal relationship from XLO graph: Reciprocal relationship from ABBV gra…
GILEAD GILEAD 90% upfront and milestone payments under our collaboration and license agreements with Gilead
CELG-RI CELG-RI 72% voluntary cooperation in other areas. Individual EU member states will continue to be responsible for assessing non-clinical (e.g., economic, social, ethical) aspects of health technology, and making…
CELG-RI CELG-RI 72% Reciprocal relationship from CELG-RI graph: Reciprocal relationship from XLO graph: voluntary cooperation in other areas. Individual EU member states will continue to be responsible for assessing non…
HOWL Werewolf Therapeutics, Inc. 72% Reciprocal relationship from HOWL graph: Reciprocal relationship from XLO graph: Reciprocal relationship from HOWL graph: Reciprocal relationship from XLO graph: Reciprocal relationship from HOWL gra…

Xilio Therapeutics, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
XLO-DEBT Debt stack $6.6M 90% Market cache reports total debt of $6.6M.
XLO-DEBT-13665 Xbrl Convertible 90% xbrl convertible detail from xbrl 2021-12-31.
XLO-DEBT-13664 Warrants outstanding: 28000 90% xbrl warrant detail from xbrl 2025-12-31.

Xilio Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Xilio Therapeutics, Inc..

Xilio Therapeutics, Inc. Ownership

HolderNameConfidenceEvidence
XLO-OWNER-MORGAN-STANLEY MORGAN STANLEY 90% 13F overlay lists MORGAN STANLEY as top holder; 2 tracked holders.

Xilio Therapeutics, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
CRBP Corbus Pharmaceuticals Holdings, Inc. 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
BLRX BioLineRx Ltd. 100.00 2
ALXO ALX Oncology Holdings Inc. 100.00 2
WHWK Whitehawk Therapeutics, Inc. 100.00 2
AVIR Atea Pharmaceuticals, Inc. 100.00 2
BLLN BillionToOne, Inc. 100.00 2
CYTOF Altamira Therapeutics Ltd. 100.00 2
CTMX CytomX Therapeutics, Inc. 100.00 2
CTNM Contineum Therapeutics, Inc. 100.00 2
ANIK Anika Therapeutics, Inc. 100.00 2
ANL Adlai Nortye Ltd. 100.00 2
CLYM Climb Bio, Inc. 100.00 2
DEO Diageo plc 100.00 2
DAWN Day One Biopharmaceuticals Inc 100.00 2
ANRO Alto Neuroscience, Inc. 100.00 2
AXSM Axsome Therapeutics, Inc. 100.00 2
AORT Artivion, Inc. 100.00 2
AVBP ArriVent BioPharma, Inc. 100.00 2
CYTK Cytokinetics, Incorporated 100.00 2
View XLO supply chain intel →

Explore the full interactive supply chain map for Xilio Therapeutics, Inc..

Open XLO supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map